NCT06244316 · Interventional trial
A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease.
Overall registry status Completed
Phase 2
Conditions Dry Eye Disease
Delaware Valley sites
- The Scheie Eye Institute · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory